Floatz logo

Therapeutic Asset Ratings

373 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Daraxonrasib
Pancreatic Cancer
Revolution Medicines, Inc.P3CCC (54)
ibi343
Pancreatic Cancer
Zhejiang UniversityP3CCC (54)
Ruxolitinib
Pancreatic Cancer
Incyte CorporationP3CCC (54)
Adebrelimab
Pancreatic Cancer
Jinling Hospital, ChinaP2CCC (54)
Atezolizumab
Pancreatic Cancer
Cancer Research UKP2CCC (54)
Avutometinib
Pancreatic Cancer
Washington University School of MedicineP2CCC (54)
Defactinib
Pancreatic Cancer
Washington University School of MedicineP2CCC (54)
Famitinib
Pancreatic Cancer
Fudan UniversityP2CCC (54)
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Pancreatic Cancer
National University of MalaysiaP2CCC (53)
Bms-907351
Pancreatic Cancer
Joseph KimP2CCC (53)
Catequentinib
Pancreatic Cancer
RenJi HospitalP2CCC (53)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Pancreatic Cancer
Sensei Biotherapeutics, Inc.P2CCC (53)
LIDOCAINE
Pancreatic Cancer
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)P2CCC (53)
Niraparib
Pancreatic Cancer
Tempus AIP2CCC (53)
Olaparib
Pancreatic Cancer
Cambridge University Hospitals NHS Foundation TrustP2CCC (53)
Ponsegromab
Pancreatic Cancer
PfizerP2CCC (53)
Surufatinib
Pancreatic Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP2CCC (53)
Solu-Cortef
Pancreatic Cancer
Helsinki University Central HospitalP4CCC (52)
PROPOFOL
Pancreatic Cancer
Instituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranP3CCC (52)
Losartan
Pancreatic Cancer
Tanta UniversityP2CCC (52)
Tas-102
Pancreatic Cancer
National Cancer Institute (NCI)P2CCC (52)
Cediranib
Pancreatic Cancer
City of Hope Medical CenterP1CCC (52)
Gx
Pancreatic Cancer
Tianjin Medical University Cancer Institute and HospitalP2/3CCC (52)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Pancreatic Cancer
Cancer Research UKP2/3CCC (52)
Budigalimab
Pancreatic Cancer
Trishula Therapeutics, Inc.P2CCC (51)
Showing 51 to 75 of 373 assets
PreviousPage 3 of 15Next